Zell Lurie Commercialization Fund

The Zell Lurie Commercialization Fund (ZLCF) is a pre-seed investment fund established to identify and accelerate the commercialization of ideas generated within the South-East Michigan area.

Scott Collins

VP of portfolio management

5 past transactions

Neurable

Series A in 2018
Neurable Inc. is a neurotechnology company based in Cambridge, Massachusetts, founded in 2016. The company focuses on developing artificial intelligence software that translates brain activity into actionable insights, allowing users to control software and devices solely with their thoughts. Neurable's technology facilitates various applications, including gaming, operating toys, and driving vehicles, as well as enhancing experiences in virtual and augmented reality. By leveraging patented signal processing methods and a multidisciplinary approach that combines neuroscience, biology, statistics, and machine learning, Neurable aims to create high-performance brain-computer interfaces that are accessible and user-friendly.

ContentOro

Convertible Note in 2016
ContentOro provides the number one need in digital marketing today – content – in a new and unique way. Proprietary software converts millions of pages of text and images from published books into high-quality pieces of fresh and relevant content that can quickly and easily be searched, found, and added to any website to provide information and SEO benefits. This on-demand access to the world’s largest repository of professionally written content positions ContentOro to change the way digital marketers and brands acquire content for marketing.

PHASIQ

Venture Round in 2015
PHASIQ, founded in 2012, specializes in the development of immunoassay kits that facilitate the efficient and cost-effective measurement of multiple health-indicator proteins from a single patient sample. Utilizing phase-separated droplets, the company offers a unique advantage by enabling the simultaneous multiplexing of proteins, which traditional methods cannot achieve. These kits are particularly beneficial for research and diagnostic applications related to cancer and various diseases impacting the immune and cardiovascular systems. By allowing life science researchers and scientists to test for a wide range of proteins concurrently, PHASIQ enhances the accuracy and efficiency of protein analysis, streamlining processes that typically require individual testing.

Reveal Design Automation

Seed Round in 2015
Reveal Design Automation is an Electronic Design Automation (EDA) start-up developing software tools to address a critical challenge in the semiconductor chip design process: formal verification of complex chip designs. With fully automated solutions enabling highly scalable Architecture Validation, formal verification runs that take days with competing solutions can now be completed in hours with Reveal. Where a typical verification cycle for a new chip design requires dozens to hundreds of such verification runs, Reveal can save chip designers millions of dollars in verification expense, reduce time-to-market by months, and significantly improve confidence in chip design correctness.

AdAdapted

Seed Round in 2014
AdAdapted is a digital engagement and insights platform for CPG brands and agencies. Its platform offers CPG brands the ability to directly target their primary consumers in the apps they use to plan and shop. It was founded in 2012 and headquartered in Ann Arbor, Michigan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.